Hims (HIMS): FY25 Q2 earnings call, Aug 4, 2025
No Kalshi or Polymarket word markets were listed for Hims’s Aug 4, 2025 earnings call (FY25 Q2). The transcript is searchable below (quotes of at most 25 words).
UpdatedTranscript
quotes of at most 25 wordsSpeaker-labelled transcript · Source and credits · Used to count words; quotes of at most 25 words.
17 matches for “GLP-1”; 5 quoted, at least 25 words apart.
…data reflected those customers on a personalized treatment plan inclusive of a GLP-1 treatment for 6 months reported losing on average 10.3% of their body…
…Strong performance across these offerings helped offset headwinds that came from offboarding GLP-1 subscribers on commercially available dosages as well as a decline in our…
…primarily as a result of the offboarding of a portion of our GLP-1 subscribers. Now shifting to profitability. The second quarter was an exceptional demonstration…
…year is based on the following assumptions: First, the fulfillment of compounded GLP-1 treatment available through our platform no longer utilizes 503B outsourcing facilities. This…
…oral offering and the demand for management of side effects through compounded GLP-1s, we remain confident in our weight loss specialty's ability to deliver at…
Agents: this page as TSV at /api/v1/appearances/hims:2025-08-04:earnings_call · words: /api/v1/brief?appearance=hims:2025-08-04:earnings_call · columnar JSON in #parrot-data · llms.txt · MCP